Akovaz (Avadel Legacy Pharmaceuticals, LLC)
Welcome to the PulseAid listing for the Akovaz drug offered from Avadel Legacy Pharmaceuticals, LLC. This alpha-Adrenergic Agonist [EPC],Adrenergic alpha-Agonists [MoA],beta-Adrenergic Agonist [EPC],Adrenergic beta-Agonists [MoA],Norepinephrine Releasing Agent [EPC],Increased Norepinephrine Activity [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Avadel Legacy Pharmaceuticals, LLC |
| NON-PROPRIETARY NAME: | ephedrine sulfate |
| SUBSTANCE NAME: | EPHEDRINE SULFATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | alpha-Adrenergic Agonist [EPC],Adrenergic alpha-Agonists [MoA],beta-Adrenergic Agonist [EPC],Adrenergic beta-Agonists [MoA],Norepinephrine Releasing Agent [EPC],Increased Norepinephrine Activity [PE] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2016-08-01 |
| END MARKETING DATE: | 0000-00-00 |
Akovaz HUMAN PRESCRIPTION DRUG Details:
| Item Description | Akovaz from Avadel Legacy Pharmaceuticals, LLC |
| LABELER NAME: | Avadel Legacy Pharmaceuticals, LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(mg/mL) |
| START MARKETING DATE: | 2016-08-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 76014-005_d7ea6982-e9ad-40f8-b2d6-a2d322a78359 |
| PRODUCT NDC: | 76014-005 |
| APPLICATION NUMBER: | NDA208289 |
Other EPHEDRINE SULFATE Pharmaceutical Manufacturers / Labelers:
